rs144147839
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_020247.5(COQ8A):āc.1286A>Gā(p.Tyr429Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000258 in 1,613,492 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y429H) has been classified as Uncertain significance.
Frequency
Consequence
NM_020247.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COQ8A | NM_020247.5 | c.1286A>G | p.Tyr429Cys | missense_variant | 11/15 | ENST00000366777.4 | NP_064632.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COQ8A | ENST00000366777.4 | c.1286A>G | p.Tyr429Cys | missense_variant | 11/15 | 1 | NM_020247.5 | ENSP00000355739.3 | ||
ENSG00000288674 | ENST00000366779.6 | n.*6013A>G | non_coding_transcript_exon_variant | 28/32 | 2 | ENSP00000355741.2 | ||||
ENSG00000288674 | ENST00000366779.6 | n.*6013A>G | 3_prime_UTR_variant | 28/32 | 2 | ENSP00000355741.2 |
Frequencies
GnomAD3 genomes AF: 0.000243 AC: 37AN: 152014Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000311 AC: 78AN: 250510Hom.: 0 AF XY: 0.000302 AC XY: 41AN XY: 135712
GnomAD4 exome AF: 0.000259 AC: 379AN: 1461478Hom.: 1 Cov.: 38 AF XY: 0.000292 AC XY: 212AN XY: 727066
GnomAD4 genome AF: 0.000243 AC: 37AN: 152014Hom.: 0 Cov.: 33 AF XY: 0.000323 AC XY: 24AN XY: 74228
ClinVar
Submissions by phenotype
not provided Uncertain:3Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 26, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Feb 06, 2024 | BP4 - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Mar 24, 2016 | The Y429C missense mutation in the ADCK3 gene has been reported previously in association with adult-onset cerebellar ataxia according to the Human Gene Mutation Database (Hovarth et al., 2012). - |
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jan 26, 2024 | Available data are insufficient to determine the clinical significance of the variant at this time. The frequency of this variant in the general population is higher than would generally be expected for pathogenic variants in this gene. (http://gnomad.broadinstitute.org) Computational tools disagree on the variant's effect on normal protein function. - |
Autosomal recessive ataxia due to ubiquinone deficiency Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 28, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Jul 09, 2020 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 10, 2024 | Variant summary: COQ8A c.1286A>G (p.Tyr429Cys) results in a non-conservative amino acid change in the ABC1 atypical kinase-like domain (IPR004147) of the coded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00031 in 250510 control chromosomes. c.1286A>G has been reported in the literature in two siblings affected with Autosomal Recessive Adult-onset cerebellar ataxia, without second reportable variant (Horvath_2012). These report(s) do not provide unequivocal conclusions about association of the variant with Autosomal Recessive Ataxia Due To Ubiquinone Deficiency. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 22036850). ClinVar contains an entry for this variant (Variation ID: 214044). Based on the evidence outlined above, the variant was classified as uncertain significance. - |
COQ8A-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 20, 2024 | The COQ8A c.1286A>G variant is predicted to result in the amino acid substitution p.Tyr429Cys. This variant was reported without a second variant in COQ8A in an individual with adult-onset cerebellar ataxia (Horvath et al 2012. PubMed ID: 22036850). This variant is reported in 0.061% of alleles in individuals of European (non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at